Filing Details
- Accession Number:
- 0001181431-13-027758
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-14 19:00:32
- Reporting Period:
- 2013-05-13
- Filing Date:
- 2013-05-14
- Accepted Time:
- 2013-05-14 19:00:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1114220 | Keryx Biopharmaceuticals Inc | KERX | Pharmaceutical Preparations (2834) | 134087132 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1434718 | Iii F James Oliviero | C/O Keryx Biopharmaceuticals, Inc. 750 Lexington Avenue New York NY 10022 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-05-13 | 29,363 | $8.34 | 558,842 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Of the 558,842 shares, 453,914 are shares of restricted stock.
Billionaire Hedge Funds
